Pfizer, every mention
10 scenes · ← back to Pfizer
tap a year for its mentions
every year anyone Safi Bahcall 3Vijay Pande 1Russ Altman 1Michael Copeland 1Lada Nuzhna 1Koki Hirasaki 1Jonathan Lim 1Jeff Woo 1
Verbatim, from the transcripts: the passages where Pfizer comes up
The Brutal Truth About Biotech: Why $2B Per Drug Is Killing Innovation
- ▶ 53:21 Lada Nuzhna I think Pfizer terminated their GLP-one program because internally they decided that actually, like, uh, chronic disease injectables, I don't think patients want that.
The 5 Revolutions in Cancer Treatment
- ▶ 2:19 Jonathan Lim He was the global head of oncology at Pfizer, and it was his teams who discovered drugs like axitinib and crizotinib, important cancer therapies in precision medicine.
a16z Podcast | Incenting Innovation Inside, Loonshots to Moonshots
- ▶ 4:20 Safi Bahcall So the parallel, China, India, and the Islamic empires were a lot like the Merck, Pfizer, and Novartis of today.
- ▶ 22:18 Safi Bahcall Let's say you, Sonal, are a manager at Pfizer.
- ▶ 30:50 Safi Bahcall If they're at Pfizer and they have no stake in outcome and a ton of stake in getting promoted, what do you think they're going to do?
What’s with All the Bio M&A in 2019?: A Quick Take
- ▶ 1:36 Koki Hirasaki Um, Pfizer lost, uh, exclusivity on Lyrica.
a16z Podcast | The Genetics Of Drug Delivery
- ▶ 1:06 Russ Altman I also have collaborations with Pfizer and Genentech and Karius and Second Ohm, and I am a founder of Personalis, which does immuno-oncology.
a16z Podcast | Move Fast But Don't Break Things (When It Comes to Computational Biology)
- ▶ 0:19 Michael Copeland We have Jeff Kindler, who is the former CEO of a little company you might've heard of Pfizer, um, and who's now, um, an advisor and investor in, in the biotech space.
a16z Podcast | Nootropics and the Best Version of Your Brain, Yourself
On Machine Learning in Medicine and More
- ▶ 9:31 Vijay Pande I could see a Pfizer buying Omada, you know, and maybe coupling with a drug or maybe not.